ARTICLE | Clinical News
NeuroSearch gains after Huntexil data
February 4, 2010 12:45 AM UTC
NeuroSearch A/S (CSE:NEUR) jumped DKK83 (98%) to DKK168 on Wednesday after reporting that twice-daily Huntexil pridopidine met the primary endpoint of significantly improving voluntary motor function ...